<p>Russia's single-dose Sputnik Light vaccine against Covid-19 has demonstrated 93.5 per cent efficacy in Paraguay, with data taken from the South American country's vaccination campaign, the Russian Direct Investment Fund (RDIF) said on Wednesday.</p>.<p>Developed by Moscow's Gamaleya Institute, Sputnik Light had shown 79.4 per cent efficacy when it was first authorised for use in May.</p>.<p>The RDIF, citing data from Paraguay's health ministry collected by July 30, said the vaccine had proved highly effective among more than 320,000 people.</p>.<p>"The use of the single-component vaccine Sputnik Light allows the Paraguayan authorities to shorten vaccination periods for the population and speed up the formation of collective immunity," RDIF head Kirill Dmitriev said in a statement. </p>
<p>Russia's single-dose Sputnik Light vaccine against Covid-19 has demonstrated 93.5 per cent efficacy in Paraguay, with data taken from the South American country's vaccination campaign, the Russian Direct Investment Fund (RDIF) said on Wednesday.</p>.<p>Developed by Moscow's Gamaleya Institute, Sputnik Light had shown 79.4 per cent efficacy when it was first authorised for use in May.</p>.<p>The RDIF, citing data from Paraguay's health ministry collected by July 30, said the vaccine had proved highly effective among more than 320,000 people.</p>.<p>"The use of the single-component vaccine Sputnik Light allows the Paraguayan authorities to shorten vaccination periods for the population and speed up the formation of collective immunity," RDIF head Kirill Dmitriev said in a statement. </p>